Thrombotic thrombocytopenia after Ad26. COV2. S vaccination
KL Muir, A Kallam, SA Koepsell… - New England Journal …, 2021 - Mass Medical Soc
KL Muir, A Kallam, SA Koepsell, K Gundabolu
New England Journal of Medicine, 2021•Mass Medical SocThrombotic Thrombocytopenia after Ad26. COV2. S Vaccine A 48-year-old woman
presented with a 3-day history of fatigue and abdominal pain 2 weeks after receiving the
Ad26. COV2. S vaccine. She had a low platelet count and was found to have cerebral
venous sinus thrombosis and clots in the right hepatic and splenic veins. Testing for
antibody to PF4–polyanion was positive.
presented with a 3-day history of fatigue and abdominal pain 2 weeks after receiving the
Ad26. COV2. S vaccine. She had a low platelet count and was found to have cerebral
venous sinus thrombosis and clots in the right hepatic and splenic veins. Testing for
antibody to PF4–polyanion was positive.
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccine
A 48-year-old woman presented with a 3-day history of fatigue and abdominal pain 2 weeks after receiving the Ad26.COV2.S vaccine. She had a low platelet count and was found to have cerebral venous sinus thrombosis and clots in the right hepatic and splenic veins. Testing for antibody to PF4–polyanion was positive.
The New England Journal Of Medicine